小儿急性髓系白血病：国际进展与未来方向 - Suppr

Suppr

超能文献

Pediatric acute myeloid leukemia: international progress and future directions.

作者信息

Kaspers G J L, Creutzig U

出版信息

Leukemia. 2005 Dec;19(12):2025-9. doi: 10.1038/sj.leu.2403958.

DOI:10.1038/sj.leu.2403958

PMID:16304569

Abstract

摘要

相似文献

Pediatric acute myeloid leukemia: international progress and future directions.

Leukemia. 2005 Dec;19(12):2025-9. doi: 10.1038/sj.leu.2403958.

Prognostic relevance of risk groups in the pediatric AML-BFM trials 93 and 98.

Ann Hematol. 2004;83 Suppl 1:S112-6. doi: 10.1007/s00277-004-0850-2.

Prognosis in therapy-related acute myeloid leukemia and impact of karyotype.

J Clin Oncol. 2004 Jun 15;22(12):2510-1. doi: 10.1200/JCO.2004.99.301.

Alternative donor transplantation in acute myeloid leukemia: which source and when?

Curr Opin Hematol. 2007 Mar;14(2):152-61. doi: 10.1097/MOH.0b013e328017f64d.

Epidemiology and clinical burden of acute myeloid leukemia.

Expert Rev Anticancer Ther. 2003 Oct;3(5):695-710. doi: 10.1586/14737140.3.5.695.

Pediatric acute myeloid leukemia: towards high-quality cure of all patients.

Haematologica. 2007 Nov;92(11):1519-32. doi: 10.3324/haematol.11203.

Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials.

Leukemia. 2005 Dec;19(12):2139-42. doi: 10.1038/sj.leu.2403854.

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

Leukemia. 2005 Dec;19(12):2101-16. doi: 10.1038/sj.leu.2403927.

Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985.

Jpn J Clin Oncol. 1989 Dec;19(4):338-47.

Acute leukemia. Modern management.

Minn Med. 1974 Jul;57(7):532-7.

引用本文的文献

Hispidulin: a potential alternative to vorinostat against HDAC1 for acute myeloid leukemia.

Discov Oncol. 2025 Jul 22;16(1):1389. doi: 10.1007/s12672-025-03182-y.

Probiotics and nanoparticle-mediated nutrient delivery in the management of transfusion-supported diseases.

Front Cell Infect Microbiol. 2025 Apr 11;15:1575798. doi: 10.3389/fcimb.2025.1575798. eCollection 2025.

Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.

Mol Biomed. 2024 Jan 2;5(1):1. doi: 10.1186/s43556-023-00162-y.

Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.

J Clin Oncol. 2023 Nov 1;41(31):4881-4892. doi: 10.1200/JCO.22.02836. Epub 2023 Aug 2.

Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia.

Front Pediatr. 2023 Feb 17;11:1117988. doi: 10.3389/fped.2023.1117988. eCollection 2023.

Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant.

Blood. 2022 Mar 17;139(11):1670-1683. doi: 10.1182/blood.2021013972.

Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.

Pediatr Blood Cancer. 2022 Jan;69(1):e29313. doi: 10.1002/pbc.29313. Epub 2021 Sep 2.

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.

Cancers (Basel). 2021 May 12;13(10):2336. doi: 10.3390/cancers13102336.

Treatments for children and adolescents with AML.

Blood Res. 2020 Jul 31;55(S1):S5-S13. doi: 10.5045/br.2020.S002.

Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

J Clin Oncol. 2020 Jul 20;38(21):2398-2406. doi: 10.1200/JCO.19.02856. Epub 2020 Apr 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验